scorecardresearch
Add as a preferred source on Google
Thursday, November 20, 2025
TopicCholesterol

Topic: cholesterol

Daily statins vs ‘one-and-done’ gene therapy: India watches a cholesterol shift

A report on gene-editing drugs renews debate around long-term statin use as Indian cardiologists caution that risk assessment still guides therapy.

Experimental drug promising to bring down bad cholesterol by up to 69% completes early stage trial

Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol levels. Commonly used drugs work by inhibiting cholesterol-causing enzyme.

Cardiovascular monitoring via nanotech. IIT-Guwahati researchers’ device promises faster, precise test

It is still in initial stages & could eventually be integrated with mobile phones, enabling patients to monitor blood health on the go. Clinical trials conducted with around 50 patients.

India gets 1st guidelines for managing lipid levels, the biggest risk factor for heart attack, stroke

For the first time, the guidelines are aimed at clinicians, individuals and medical laboratories. The cut-off for various lipid markers was modified based on risk factors.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Want to boost your child’s growth? Replace rice with millets, says India-led nutrition study

Study — led by Dr S. Anitha, senior scientist, nutrition, at ICRISAT — is a review and analysis of 8 previously published studies. It was published in the journal 'Nutrients' this month.

On Camera

Hasina’s was a trial in absentia, but not a trial without justice

The Sheikh Hasina trial represents an inflection point in the struggle to place citizens above rulers and prevent the next massacre.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Can’t stay behind tech curve anymore, must catch up—Vice Chief of Navy Staff ahead of Swavlamban 2025

New Delhi: Noting that India cannot afford to stay behind the technology curve when it comes to war-fighting, Vice Chief of the Naval Staff...

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.